5-YEAR SURVIVAL OF NONSMALL-CELL LUNG-CANCER PATIENTS AFTER TREATMENT WITH CHEMOTHERAPY ALONE

被引:0
作者
STATHOPOULOS, GP
机构
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:565 / 566
页数:2
相关论文
共 50 条
[21]   SURGICAL TREATMENT OF LUNG-CANCER 5-YEAR SURVIVAL - MAJOR SURGICAL COMPLICATIONS [J].
DENEFFE, G ;
DAENEN, W ;
SUY, R ;
STALPAERT, G .
ACTA CHIRURGICA BELGICA, 1978, 77 (04) :311-316
[22]   PREDICTORS OF 5-YEAR SURVIVAL AND CURABILITY IN SMALL-CELL LUNG-CANCER [J].
CROWN, JPA ;
CHAHINIAN, AP ;
JAFFREY, IS ;
GLIDEWELL, OJ ;
KANEKO, M ;
HOLLAND, JF .
CANCER, 1990, 66 (02) :382-386
[23]   COUNTING THE COSTS OF CHEMOTHERAPY IN A NATIONAL-CANCER-INSTITUTE-OF-CANADA RANDOMIZED TRIAL IN NONSMALL-CELL LUNG-CANCER [J].
JAAKKIMAINEN, L ;
GOODWIN, PJ ;
PATER, J ;
WARDE, P ;
MURRAY, N ;
RAPP, E .
JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (08) :1301-1309
[24]   Predicting postrecurrence survival among completely resected nonsmall-cell lung cancer patients [J].
Williams, BA ;
Sugimura, H ;
Endo, C ;
Nichols, FC ;
Cassivi, SD ;
Allen, MS ;
Pairolero, PC ;
Deschamps, C ;
Yang, P .
ANNALS OF THORACIC SURGERY, 2006, 81 (03) :1021-1027
[25]   PALLIATIVE CHEMOTHERAPY FOR ADVANCED NONSMALL CELL LUNG-CANCER [J].
SMITH, IE .
BRITISH MEDICAL JOURNAL, 1994, 308 (6926) :429-430
[26]   RELATIONSHIP OF MEDIASTINAL NODE METASTASES AND CELL TYPE TO 5-YEAR SURVIVAL IN PATIENTS OPERATED ON FOR LUNG-CANCER [J].
BAUM, GL ;
RUBENSTEIN, I ;
KALTER, J ;
LIEBERMAN, Y ;
PAUZNER, Y .
THORAX, 1977, 32 (05) :651-652
[27]   CHALLENGES OF PREOPERATIVE CHEMOTHERAPY IN NONSMALL CELL LUNG-CANCER [J].
JOHNSON, DH .
LUNG CANCER, 1994, 10 :S195-S203
[28]   Efficacy of cascade-primed cell infusion as an adjuvant immunotherapy with concurrent chemotherapy for patients with nonsmall-cell lung cancer: A retrospective observational study with a 5-year follow-up [J].
Li, Hong ;
Zhang, Zhen ;
Duan, Xiaoran ;
Maimela, Nomathamsanqa Resegofetse ;
Yang, Shuangning ;
Zhao, Xuan ;
Huang, Jianmin ;
Zhang, Yi .
CYTOTHERAPY, 2020, 22 (01) :35-43
[29]   RADIOTHERAPY AND CHEMOTHERAPY FOR INOPERABLE NONSMALL CELL LUNG-CANCER [J].
BLEASDALE, C ;
JONES, B .
POSTGRADUATE MEDICAL JOURNAL, 1995, 71 (837) :393-396
[30]   SHOULD NONSMALL CELL-CARCINOMA OF THE LUNG BE TREATED WITH CHEMOTHERAPY - PRO - CHEMOTHERAPY IS FOR NONSMALL CELL LUNG-CANCER [J].
MASTERS, GA ;
VOKES, EE .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 151 (05) :1285-1287